Cervix BT - 2016

CONCLUSIONS (Vienna experience 1998-2008) MRI assisted treatment planning in defintive intracavitary cervical cancer brachytherapy Plus risk adapted interstitial brachytherapy plus 3D CRT +/- cis-PLATINUM (n=228)

Local control



tumours < 5 cm: ~95-100+%

D90: 90-95 Gy D90: 90+ Gy

tumours ≥ 5 cm: ~90%

 Low rate of late side effects

Grade 3 and 4: <5% per organ site